Here is a strange fact about CBG: the cannabis plant spends the entire growing season destroying it. Every cannabinoid starts as CBGA (cannabigerolic acid), the biochemical raw material from which THC, CBD, and CBC all develop (more on that in CBC vs CBG). As the plant matures, enzymes convert nearly all of that CBGA into those other compounds. By harvest, a typical cannabis plant contains less than 1% CBG by weight. You have to catch it early, breed specifically for it, or accept the cost of working with young plants. That scarcity is not a marketing story. It is chemistry. Scarce doesn’t mean proven, though, so here is what we actually know. In the first human trial, 34 healthy adults took 20mg of CBG or a placebo. On CBG they felt less anxious and less stressed, did better on a verbal memory test, and showed no signs of impairment (Cuttler et al., 2024). That is the clearest read on CBG for focus: less mental noise, not a jolt of energy. Product ideas that fit the day are in our best cannabis for daytime guide.
🧪 Lab Tested | 👩💼 Woman-Owned | 🏆 Est. 2017
Research context: The mechanisms in this article are based on preclinical (cell and animal) research and limited human observational data. CBG is not an approved drug or treatment. Nothing here constitutes medical advice or a claim that CBG treats, prevents, or cures any condition. Consult a physician before making health decisions based on this content.
What CBG Is and Why It Costs More
Cannabigerol (CBG) is a non-psychoactive cannabinoid. It begins its life as CBGA, the acidic precursor that serves as the biosynthetic starting point for the entire cannabinoid family. As a cannabis plant matures, specific enzymes convert CBGA into THCA, CBDA, and CBCA (the acidic precursors to THC, CBD, and CBC respectively). By the time a plant reaches harvest, almost all of the CBG has been converted away. Most cultivated cannabis contains 1% CBG or less by dry weight.
Getting concentrated CBG into a product requires one of three approaches: harvesting early before conversion is complete, breeding strains that express high CBG by retaining more CBGA in the plant, or extracting from immature plants that haven’t yet run the full conversion process. None of these is as efficient or cost-effective as working with mature CBD-dominant hemp, which is why CBG products carry a higher price per milligram than equivalent CBD products. The markup is not a premium for novelty. It is a reflection of the additional steps required to obtain meaningful CBG concentrations.
CBG does not produce psychoactivity. It does not activate CB1 receptors with the potency that generates THC’s intoxicating effect. Its receptor profile is broader than CBD’s, with meaningful activity at adrenergic receptors and serotonin receptors in addition to the cannabinoid receptor system, and that broader profile is what makes its effect on focus and energy pharmacologically interesting.
Four Mechanisms Behind the Focus Effect
Start with the human evidence: in the one trial so far, 20mg of CBG lowered anxiety and stress and sharpened verbal memory, with no impairment (Cuttler et al., 2024). The four receptor systems below are how lab studies suggest that could happen. None has been tested in people specifically for focus, so treat them as the likely why, not proof.
FAAH Activity
Lab studies suggest CBG may slow FAAH (fatty acid amide hydrolase), the enzyme that breaks down anandamide, one of the body’s own cannabinoids. More anandamide sticking around could gently tune the circuits tied to attention, without the push THC gives. That part is still theory. No one has measured it in people.
Alpha-2 Activity
In lab studies, CBG acts on alpha-2 adrenoceptors as a potent agonist, meaning it switches them on (Cascio et al., 2010). These receptors work as a brake on norepinephrine release, so switching them on would tend to quiet that signal rather than boost it. That makes this pathway a poor fit for a “more alertness” story, and one more reason the clarity people describe reads as less noise rather than more drive. CBD does not share this alpha-2 activity.
5-HT1A Activity
CBG also acts on 5-HT1A serotonin receptors, the receptor CBD works on, though in that same lab study it blocked them rather than switching them on (Cascio et al., 2010). Either way, the first human trial found 20mg of CBG lowered anxiety and stress compared with placebo (Cuttler et al., 2024). The contribution to focus is indirect. Anxiety and distractibility compete directly for working memory resources, so reducing the anxious signal can free up cognitive capacity without stimulating the system in any conventional sense. It is not an energy boost. It is the removal of an energy drain.
CB1 and CB2 Activity
CBG binds both CB1 and CB2 receptors, but in the same lab study, at high concentrations, it blocked CB1 rather than switching it on (Cascio et al., 2010). That is a big part of why it doesn’t get you high. Any effect on the glutamate and dopamine circuits behind working memory is still theoretical, so we don’t count it as a focus mechanism yet.
CBG vs. CBD: What Is Actually Different
CBD and CBG overlap on 5-HT1A serotonin receptors, and lab studies suggest both may affect FAAH, the enzyme that breaks down anandamide. That overlap is part of why both get described as calming. The practical difference lives in the systems they do not share.
CBG acts on alpha-2 adrenoceptors. CBD does not. At CB1, neither one flips the switch the way THC does: CBG blocked it in lab work at high concentrations, and CBD acts as a negative allosteric modulator, changing how the receptor responds to other activators without turning it on. What people notice in practice is that CBD can feel relaxing to the point of sedation at moderate and higher doses, while CBG tends to stay clearer across a wider dose range.
The two are commonly combined, which is the logic behind CBG-boosted CBD products. CBD provides stronger broad-spectrum anxiolytic coverage. CBG adds alpha-2 activity that CBD does not have. Whether the combination produces effects greater than either alone is not established in controlled trials, but the receptor coverage rationale is solid. Some users find that pairing them lets them take less of each than they would need individually to reach the same outcome.
For focus specifically: if CBD alone feels too heavy or calming for daytime use, CBG or a CBG-dominant blend is the more pharmacologically appropriate alternative. That is not a judgment about which product is better in general. It reflects where in the receptor system each one acts.
THCV, the Other Half of the Focus Formula
CBG and THCV reach focus from two different directions (THCV vs CBG breaks it down), which is why our focus gummy runs both. THCV (the V stands for varin, a small structural change) behaves like THC in reverse. Where THC switches on the CB1 receptor and brings the high and the munchies with it, THCV blocks that receptor.
CBG works on a different part of the system, as the mechanisms above cover. So you are not doubling up on one pathway, you are covering two.
That is why Fit & Focused carries 20mg CBG and 15mg THCV in the same gummy rather than picking one. The price note above applies here too, since THCV is just as scarce in the plant, so you will see it priced above a standard CBD gummy. The full THCV vs THC breakdown has the research, and the THCV collection has everything we put it in. Every gummy we make with CBG is in our full CBG gummies collection.
Dosing Guide: Starting Points and Timing
Dosing note: The ranges below are starting reference points drawn from preclinical research, product formulation specs, and user experience data. They are not medical prescriptions. Individual response varies by body weight, tolerance, liver metabolism, and baseline endocannabinoid tone. Start low. Assess over three to five sessions before adjusting upward.
| Level | CBG Amount | Expected Profile | Timing (Tincture) | Best Format |
| New to CBG | 5 to 10mg | Subtle clarity, mild anxiety reduction. May not feel clearly distinct from CBD at this range. A useful calibration starting point. | 30 to 60 min before work | Tincture (sublingual) |
| Established user | 15 to 25mg | Clearer cognitive calm, reduced mental friction. Most commonly reported effective range for focus applications in user experience data. | 30 to 45 min before task | Tincture or CBG-boosted cart |
| Tolerance-adjusted | 25 to 50mg | Strong anxiolytic effect. Some users at this range report the profile shifts toward relaxation rather than focused alertness. Morning or early afternoon only. | 45 to 60 min before work | Tincture |
| CBG plus CBD combo | 10 to 15mg CBG + 20 to 30mg CBD | Broader receptor coverage. CBD’s stronger broad-spectrum anxiolytic activity paired with CBG’s different receptor profile. Common in CBG-boosted CBD products. | 30 to 60 min before work | CBG-boosted tincture or cart |
The general pattern in user experience: CBG sits closer to the activating end of the cannabinoid spectrum than CBD. Evening use is less common with CBG-forward products, particularly at moderate and higher doses, because many people find it less sleepy than CBD. Morning and early afternoon are the better windows for focus applications.
Sublingual technique matters: Hold CBG tincture under the tongue for 60 to 90 seconds before swallowing. Some of the dose absorbs under the tongue, which may help it kick in sooner than a gummy. Swallow right away and it works like an edible, with slower, more variable absorption. The technique costs nothing, so it is worth the minute.
Tincture, Vape, or Gummy: Format Comparison
Tinctures: most predictable for focus work
A sublingual tincture gives the most consistent onset and duration control. Hold under the tongue, onset in 15 to 30 minutes, effect window of 4 to 6 hours. The drop-by-drop format allows small dose adjustments across sessions that pre-measured formats don’t permit. For anyone calibrating CBG for a specific use case, tinctures provide the feedback loop needed to find the right dose before committing to any particular amount.
CBG-boosted vape carts: fastest onset
Inhaled cannabinoids reach peak blood concentration within 5 to 15 minutes. The trade-off is duration: inhalation typically produces a 2 to 3 hour window rather than the 4 to 6 hours from a tincture. For a shorter, defined focus block or a situation where timing is tight, a CBG-boosted CBD cart works well. The CBG content per draw in a boosted product is lower than in a dedicated CBG tincture, so the total dose delivered varies significantly by number of draws and inhalation depth. This format favors users who want quick onset rather than precise milligram control. If you’d rather vape for focus, our sativa cart picks cover the THC side.
Gummies and edibles: slowest onset, longest duration
Oral CBG goes through first-pass liver metabolism before reaching systemic circulation. Onset ranges from 45 to 90 minutes, peak may arrive 2 to 3 hours after consumption, and duration can extend 6 to 8 hours. For a long work block with enough lead time to plan, edibles are viable. For spontaneous use or situations that need a reliable onset window, they are the least practical format.
CBG and Drug Tests
Standard drug panels (SAMHSA-5, SAMHSA-10, and most employer urine immunoassays) screen for THC-COOH, opioid metabolites, cocaine metabolites, amphetamines, and phencyclidine. CBG is not on that list. CBG itself will not trigger a positive result on any standard panel because no standard panel tests for it.
The relevant question for CBG users is what else is in the product. A CBG isolate or broad-spectrum product with Delta 9 THC removed carries no drug test risk from the CBG itself and no residual THC to accumulate. A full-spectrum CBG product retains trace Delta 9 THC alongside the CBG, because full-spectrum extraction preserves the complete cannabinoid profile of the plant. At typical serving sizes, the trace THC in a compliant full-spectrum hemp product is low enough that accumulation to detectable levels is unlikely for most users at standard dosing frequency, but it cannot be guaranteed. Individual metabolism, testing frequency, and panel sensitivity all affect where that line sits.
For anyone subject to zero-tolerance drug testing: choose a broad-spectrum or isolate-based CBG product rather than full-spectrum. Confirm on the batch COA that Delta 9 THC is at or near non-detect. The batch COA for TribeTokes products is always available at tribetokes.com/certificates-of-analysis.
TribeTokes CBG Products
Dedicated CBG Tincture
CBG Tincture | CBD + CBGa Boosted | 1,800 MG
★★★★★ 4.88 from 17 reviews
CBG
Isolate Blend
1,800mg
60 servings
No THC
1,800mg CBG with CBD and CBGa in an organic MCT oil base. 60 servings per bottle. Hold under the tongue 60 to 90 seconds for best onset. Isolate formula with no THC. Batch-specific lab results at tribetokes.com/certificates-of-analysis. Lemon mint flavor. Keto-friendly base.
CBG-Boosted CBD Vape Carts
CBD Full Gram Carts | CBG-Boosted | Pick Your Strain
★★★★★ 4.97 from 495 reviews
CBD + CBG
Full Gram
Indica to Sativa
510 Thread
CBD vape cartridges with CBG added for combined receptor coverage. Fast onset for focus sessions where timing is tight. Sativa-leaning strains (Green Crack, Mango Haze, Hawaiian Dream) carry more activating terpene profiles alongside the CBG. Full gram. Standard 510-thread connection. Batch COA available at tribetokes.com/certificates-of-analysis. Comparing formats? Start with our CBG vapes.
Frequently Asked Questions
Not in the stimulant sense. CBG does not increase heart rate, cause jitteriness, or block the adenosine receptors that caffeine targets. What it may produce is the removal of friction. The first human trial found 20mg of CBG lowered anxiety and stress compared with placebo, and less background anxiety leaves more room to concentrate. The combined effect some users describe as “energy” is closer to calm clarity: less internal noise rather than more drive. Whether that translates for a given person depends on their baseline anxiety level, sensitivity, and the dose.
No. CBG is non-psychoactive. At CB1 receptors, it functions as a partial agonist without the full receptor activation that produces THC’s intoxicating effects. No euphoria, no altered perception, no impaired coordination. Some users notice a subtle mood lift or sense of mental clarity, which is pharmacologically distinct from any THC-associated high.
Both act on 5-HT1A serotonin receptors, and lab studies suggest both may affect FAAH, so they overlap. The main difference is that CBG also acts on alpha-2 adrenoceptors, which CBD does not. At moderate to higher doses, CBD tends toward sedation. CBG tends to maintain a clearer profile across the dose range. For daytime cognitive use, CBG or a CBG-dominant blend is the more appropriate pharmacological choice for most users.
A practical starting point is 10 to 15mg taken sublingually 30 to 45 minutes before focused work. Most user experience data places the effective range for focus use between 10 and 25mg. Above 25 to 30mg, some users report the profile shifts toward relaxation rather than focused alertness. Start low, hold under the tongue for 60 to 90 seconds, and assess over three to five sessions before adjusting. Individual response varies considerably.
CBG itself is not screened for on any standard drug panel, so CBG on its own carries no drug test risk. The variable is the other cannabinoids in the product. Full-spectrum CBG products contain trace Delta 9 THC; at standard doses and typical testing frequency, accumulation to detectable levels is unlikely for most users but cannot be guaranteed. For zero-tolerance drug testing environments, use a broad-spectrum or isolate-based CBG product rather than full-spectrum, and confirm Delta 9 levels on the batch COA before use.
They work through different mechanisms and suit different people. Caffeine blocks adenosine receptors, which suppresses the signal that makes you feel tired. The result is alertness plus, for many people, anxiety and jitteriness as side effects. CBG works through alpha-2, serotonin and anandamide pathways to support calm attention rather than push through fatigue. Some users combine the two: caffeine for the initial wake signal, CBG to reduce the anxious edge caffeine introduces. Neither is categorically better. The right choice depends on what is actually limiting focus for a given person.
For tinctures, take 30 to 45 minutes before the start of a focus session. For vape formats, onset is faster at 5 to 15 minutes, so timing can be closer to task start. Morning and early afternoon are the better windows for focus-oriented CBG use. Later doses, particularly above 20mg, can interfere with sleep onset in some people. Evening use makes more sense with CBD-dominant blends where CBG content is lower.
Most users describe the experience as subtle. Not dramatically different from a baseline, but slightly easier to settle into a task. The common thread in user descriptions: reduced mental static, less anxious chatter, a sense that attention lands where it is pointed without as much resistance. No euphoria, no body heaviness, nothing that would impair driving or other tasks. People who find CBD calming to the point of drowsiness often find CBG noticeably clearer in comparison. People who expect a stimulant experience are typically underwhelmed. It is not that kind of compound.
1,800mg CBG. THC-Free. Third-Party Tested on Every Batch.
Organic MCT oil base. Lemon mint. 60 servings. Woman-owned since 2017.